Indian consensus on the management of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II)-Reference-Cited by-同舟云学术

Indian consensus on the management of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II)

Published:2024-05-27 Issue:6 Volume:22 Page:453-468
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Soman Rajeev¹,Veeraraghavan Balaji²,Hegde Ashit³,Varma Subhash⁴,Todi Subhash⁵,Singh R.K.⁶,Nagavekar Vasant⁷,Rodrigues Camilla⁸,Swaminathan Subramanian⁹,Ramsubramanian V¹⁰,Ansari Abdul¹¹,Chaudhry Dhruva¹²,Pednekar Amullya¹³,Bhagat Sagar¹³,Patil Saiprasad¹³,Barkate Hanmant¹³

Affiliation:

1. Department of Infectious Diseases, Jupiter Hospital, Pune, India

2. Clinical Microbiology, Christian Medical College and Hospital, Vellore, India

3. Department of Critical care, PD Hinduja National Hospital and Medical Research Centre, Mumbai, India

4. Internal Medicine and Hematology Fortis Hospital Mohali, Mohali, India

5. Department of Critical Care and Emergency Medicine, AMRI Hospital, Kolkata, India

6. Department of Emergency Medicine, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

7. Department of Infectious Disease, Lilavati Hospital and Research Centre, Mumbai, Maharashtra, India

8. Department of Microbiology and Serology, PD Hinduja Hospital and Medical Research Centre, Mumbai, Maharashtra, India

9. Department of Infectious Diseases, Gleneagles Global Hospital, Chennai, India

10. Department of Infectious Diseases, Apollo Hospital, Chennai, India

11. Department of Critical Care Services, Nanavati Super Speciality Hospital, Mumbai, Maharashtra, India

12. Department of Pulmonary and Critical care medicine, Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences, Rohtak, Haryana, India

13. Department of Global Medical Affairs, Glenmark Pharmaceuticals Ltd, Mumbai, Maharashtra, India

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2024.2360116

Reference91 articles.

1. Centers for Disease Control and Prevention. Healthcare Facilities | CRE| HAI | CDC. 2023 [cited 2023 Nov 1]. Available from: https://www.cdc.gov/hai/organisms/cre/cre-facilities.html

2. Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study

4. Indian Council of Medical Research. Annual Report: antimicrobial resistance research and surveillance network January 2022 to December 2022. [cited 2023 Nov 1]. Available from: https://main.icmr.nic.in/sites/default/files/upload_documents/AMRSN_Annual_Report_2022.pdf

5. World Health Organization. Indian Priority Pathogen List. [cited 2023 Sep 20]. Available from: https://dbtindia.gov.in/sites/default/files/IPPL_final.pdf1

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correction;Expert Review of Anti-infective Therapy;2024-06-18